Coderblock Connect
Get ready for a groundbreaking virtual experience as Roberto Ascione, our CEO, takes center stage at the Coderblock Connect event.
Terapie digitali, le condizioni per renderle prescrivibili anche in Italia
In Italia le terapie digitali ancora non sono conosciute e si fatica a distinguerle dal mondo delle app di salute La situazione è ben diversa in Europa dove negli ultimi anni si è vista la nascita quasi esponenziale di terapie digitali certificate.
Professionisti in volo a 120 chilometri orari per ritirare il diploma di un master
A Trentinara il volo dell’angelo dei graduati dell’Executive Master di Ninja Business School Pallera: «Emozioni e adrenalina per un passaggio, simbolico ma reale, verso la professione»
Digital Therapeutics Alliance and Healthware Group Launched First DTx Policy Report
This initial DTx Policy Report is focused on providing clarity on existing and evolving policy frameworks in Europe. The report details fit-for-purpose appraisal criteria being applied in countries with formal frameworks in place and analyzing requirements through the common lens of the Health Technology Assessment (HTA) Core Model®. Converging trends are also identified to help inform areas of potential harmonization and scalability across Europe and globally.
Digital Therapeutics Alliance and Healthware Group Launched First DTx Policy Report and Website Dedicated to Helping Advance Equitable Access and Adoption of Safe and Effective DTx and Digital Medical Devices
Following the formation of the European DTx Policy Coalition by Healthware Group and the Digital Therapeutics Alliance (DTA) in June 2022, the joint team presented its inaugural report “DTx Policy Pathways: the evolving scenario in Europe; Landscape Analysis & Converging Trends” and a dedicated website on Friday, June 9th at the official press conference of the DTA Summit 2023, held in Washington DC.
Digital Therapeutics: scenario europeo, prospettive italiane
Il nuovo DTx Policy Report, curato da Healthware Group in veste di partner scientifico della Digital Therapeutics Alliance (DTA), descrive l’evoluzione delle politiche per l’accesso e la rimborsabilità dei dispositivi medici digitali in Europa, con Germania, Francia, Inghilterra e Belgio a tracciare la strada.